Disruption of brain white matter microstructure in primary Sjögren's syndrome: Evidence from diffusion tensor imaging

Rheumatology

Volumn 49, Issue 8, 2010, Pages 1530-1539

  Segal, Barbara M ^a   Mueller, Bryon A ^a   Zhu, Xiaochun ^b   Prosser, Rachel ^c   Pogatchnik, Brian ^d   Holker, Erin ^e   Carpenter, Adam F ^a   Lim, Kelvin O ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e Department of Physical Medicine and Rehabilitation ^*  (United States)

Author keywords

Brain magnetic resonance diffusion tensor imaging; Neurological involvement; Sj gren's syndrome

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SJOEGREN SYNDROME; VERBAL MEMORY; WHITE MATTER;

ADOLESCENT; ADULT; AGED; BRAIN; CASE-CONTROL STUDIES; COGNITION DISORDERS; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SJOGREN'S SYNDROME; YOUNG ADULT;

EID: 77954722961     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq070     Document Type: Article

References (49)

1. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren's syndrome. Arch Intern Med 2004;164:1275-84.
2. Segal B, Thomas W, Rogers T et al. Prevalence, severity and predictors of fatigue in primary Sjögren's syndrome. Arthritis Rheum 2008;59:1780-7.
3. Segal B, Bowman SJ, Fox PC et al. Health care utilization and predictors of health quality in primary Sjögren's syndrome. Health Qual Life Outcomes 2009;7:46.
4. Coates T, Slavotinek JP, Rischmueller M et al. Cerebral white matter lesions in primary Sjogren's sydrome: a controlled study. J Rheumatol 1999;26:1301-5.
5. Escudero D, Latorre P, Codina M, Coll-Canti J, Coll J. Central nervous system disease in Sjogren's syndrome. Ann Med Interne 1995;146:239-42.
6. Pierot L, Sauve C, Leger JM, Martin N, Koeger AC, Wechsler B. Asymptomatic cerebral involvement in Sjogren's syndrome MRI findings of 15 cases. Neuroradiology 1993;35:378-80.
7. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66: 259-67.
8. LeBihan D. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 1995;8:375-86.
9. Bammer R, Fazekas F. Diffusion imaging in multiple sclerosis. Neuroimaging Clin N Am 2002;12:71-106.
10. Kodl CT, Franc DT, Rao JP et al. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 2008;57: 3083-9.
11. Lutz J, Jager L, de Quervain D et al. White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum 2008;58:3960-9.
12. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61: 544-8.
13. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
14. Radloff LS. The centers for epidemiologic studies depression scale (CES-D): a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
15. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
16. Cleeland CS, Nakamura Y, Mendoza TR, Edwards KR, Douglas J, Serlin RC. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain 1996;67:267-73.
17. Bowman SJ, Booth DA, Platts RG. UK Sjögren's Interest Group. Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool. Rheumatology 2004;43:758-64.
18. Shikiar R, Howard K, Yu EB et al. Validation of LUP-QOL: a lupus-specific measure of health-related quality of life (HRQL). Ann Rheum Dis 2006;65:601.
19. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Neuroradiol 1987;8:351-6.
20. Wozniak JR, Krach L, Ward E et al. Neurocognitive and neuroimaging correlates of pediatric traumatic brain injury: a diffusion tensor imaging (DTI) study. Arch Clin Neuropsychol 2007;22:555-68.
21. Bosma GP, Steens SC, Petropoulos H et al. Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2004;50:3195-202.
22. Alexopoulos GS, Murphy CF, Gunning-Dixon FM et al. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry 2008; 165:238-44.
23. Szeszko PR, Ardekani BA, Ashtari M et al. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Arch Gen Psychiatry 2005;62: 782-90.
24. Bosma GP, Huizinga TW, Mooijaart SP, Van Buchem MA. Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. Am J Neuroradiol 2003;24: 850-4.
25. Jennings TA, Vivino FB, Goldberg KB, Maitz EA, Mandel S. Neurocognitive dysfunction in PSS. Arthritis Rheum 2006; 54:S257, Abstract no. 534.
26. Malinow KL, Molina R, Gordon B, Selnes OA, Provost TT, Alexander EL. Neuropsychiatric dysfunction in primary Sjögren's syndrome. Ann Intern Med 1985;103:344-9.
27. Lafitte C, Amoura A, Cacoub P et al. Neurological com-plications of primary Sjögren's syndrome. J Neurol 2001; 248:577-84.
28. Belin C, Moroni C, Callat-Vigneron N et al. Central nervous system involvement in Sjögren's syndrome evidence from neuropsychological testing and HMPA0-SPECT. Ann Med Interne 1999;150:598-604.
29. Shimony JS, Sheline YI, D'Angelo G et al. Diffuse microstructural abnormalities of normal-appearing white matter in late life depression: a diffusion tensor imaging study. Biol Psychiatry 2009;66:245-52.
30. Smith CA, Stebbins GT, Bartt RE et al. White matter anisotropy and depression symptoms in patients with HIV. J Neuropsychiatry Clin Neurosci 2008;20:458-65.
31. Filley CM, Kozora E, Brown MS et al. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus. Cogn Behav Neurol 2009; 22:38-44.
32. Zhang L, Harrison M, Heier LA et al. Diffusion changes in patients with systemic lupus erythematosus. Magn Reson Imaging 2007;25:399-405.
33. Ciccarelli O, Werring DJ, Wheeler-Kingshott CA et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56: 926-33.
34. Harboe E, Beyer MK, Greve OJ et al. Cerebral white matter hyperintensities are not increased in patients with primary Sjögren's syndrome. Eur J Neurol 2009;5:576-81.
35. Akasbi M, Ramirez M, Brito-Zeron P et al. Neurological involvement in primary Sjören's syndrome: prevalence and clinical characterization in a cohort of 482 patients. Ann Rheum Dis 2008;67(Suppl. II):486.
36. Caselli RJ, Scheithauer BW, Bowles CA et al. The treatable dementia of Sjögren's syndrome. Ann Neurol 1991; 30:98-101.
37. Spezialetti R, Bluestein HG, Peter JB, Alexander EL. Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med 1993;9:153-60.
38. Niemela RK, Hakala M. Primary Sjögren's syndrome with severe central nervous system disease. Semin Arthritis Rheum 1999;29:4-13.
39. Sakic B, Szechtman H, Keffer M, Talangbayan H, Stead R, Denburg JA. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav Immun 1992;3: 265-85.
40. Tomita M, Holman B, Santoro TJ. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett 2001;302:129-32.
41. Arnsten FT. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci 2009;10:410-20.
42. Harboe E, Tjensvoll AB, Vefring HK, Gøransson LG, Kvaløy JT, Omdal R. Fatigue in primary Sjögren's syndrome-a link to sickness behaviour in animals? Brain Behav Immun 2009;23:1104-8.
43. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-41.
44. Schmitz T, Chew LJ. Cytokines and myelination in the central nervous system. Scientific World Journal 2008;8: 1119-47.
45. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010;35:192-216.
46. Dolcos F, Kragel P, Wang L, McCarthy G. Role of the inferior frontal cortex in coping with distracting emotions. Neuroreport 2006;17:1591-4.
47. Dolcos F, McCarthy G. Brain systems mediating cognitive interference by emotional distraction. J Neurosci 2006;26: 2072-9.
48. Alexander JK, Hillier A, Smith RM, Tivarus ME, Beversdorf DQ. Beta-adrenergic modulation of cognitive flexibility during stress. J Cogn Neurosci 2007;19: 468-78.
49. Leuthi M, Meier B, Sandi C. Stress effects on working memory, explicit memory and implicit memory for neutral, emotional stimuli in healthy men. Front Behav Neurosci 2009;2:1-9.